Pluvicto

Ended Awarded Last action

Contract number
36C25023N0220
Awardee
Awarding agency
Obligated
$97,387

Award facts

Contract value 100% obligated
$97,386.93 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Millburn, NJ 07041, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 -$389,548
Supplemental Agreement for work within scope P00001 -$1,493,266
Original award $1,980,201

About this award

This federal contract award to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, is for the delivery of the radiopharmaceutical product PLUVICTO. The contract has a ceiling value of $97,386.93 and is a Blanket Purchase Agreement (BPA) call order placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).

The contract is being awarded by the Department of Veterans Affairs (VA) through its Veterans Integrated Service Network 10 (VISN 10). As a non-set-aside award, this contract provides PLUVICTO, a targeted radioligand therapy for cancer treatment, to VA medical facilities and potentially other federal healthcare agencies like the Defense Health Agency (DHA) and the National Institutes of Health (NIH). Advanced Accelerator Applications USA Inc. is a specialized manufacturer of nuclear medicine products and has held multiple Indefinite Delivery Vehicles (IDVs) and BPAs with federal agencies for the supply of radiopharmaceuticals like LUTATHERA and NETSPOT. This contract has an ultimate completion date of September 30, 2023.

Quick answers

Who was awarded contract 36C25023N0220?

36C25023N0220 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 17, 2023.

How much is contract 36C25023N0220 worth?

The government has obligated $97,387 on 36C25023N0220.

Is contract 36C25023N0220 an order under another contract?

Yes. 36C25023N0220 is a BPA call under 36F79719D0169-36C25023A0020, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C25023N0220 competed?

The extent of competition for 36C25023N0220 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award